BIOCRYST SCHEDULED TO PRESENT AT THE BIO CEO & INVESTOR CONFERENCE
Birmingham, Alabama - February 23, 2004 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) announced that Charles E. Bugg, Ph.D., Chairman and CEO, will be presenting at the BIO CEO & Investor Conference in New York on Tuesday, February 24, 2004, at 12:00 p.m. Eastern Standard Time. Interested investors can listen to the presentation live over the Internet during the conference at the following address:
What:
BioCryst Pharmaceuticals, Inc. Presentation at the
BIO CEO & Investor Conference
When:
Tuesday, February 24, 2004, at 12:00 p.m. EST
Where:
How:
Live over the Internet -- Simply log on to the web at the address above
For those unable to listen at the designated time, the webcast will remain available for replay on http://www.firstcallevents.com/service/ajwz400480694gf12.html for 90 days following the conference.
Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of small-molecule pharmaceuticals to treat cancer, cardiovascular and autoimmune diseases, and viral infections.